Contemporary Clinical Issues and Case Studies Plenary Session

Wednesday, April 13, 2011
9:00 a.m.–12:00 p.m.

Highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. In addition to the Contemporary Clinical Issues discussion, a case study format addresses topics of interest

Moderator: Carlayne E. Jackson, MD, FAAN, Member, Science Committee

"Traditional Risk Factors Play a Minor Role in the Excess Stroke Incidence in African Americans: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study"

George Howard, PhD; University of Alabama, Birmingham, AL
Discussant: TBD

"Dissonance in Diagnoses of Dementia Type During Life with Attribution Determined at Autopsy in the Honolulu-Asia Aging Study; Impact of High Prevalence of Mixed Pathology and Specificity/Non-Specificity of Clinical Manifestations in the Very Old"

Lon R. White, MD, MPH; University of Hawaii, Honolulu, HI
Discussant: David S. Knopman, MD, FAAN; Mayo Clinic, Rochester, MN

"The Effectiveness of Amantadine Hydrochloride in Improving Level of Consciousness and Functional Recovery in Patients in the Vegetative or Minimally Conscious State after Traumatic Brain Injury"

Douglas I. Katz, MD, FAAN; Boston University, Boston, MA
Discussant: Ramon R. Diaz-Arrastia, MD, PhD, FAAN; University of Texas Southwestern, Dallas, TX

In addition to the Contemporary Clinical Issues discussion, a case study format will be presented by the following presenters:

"The 2010 MS Diagnostic criteria, How to Use Them in a CIS case"

Xavier Montalban, MD
Hospital Universitari Vall d'Hebron, Barcelona, Spain

"Resting-State fMRI in the Differential Diagnosis of Dementia"

Michael Greicius, MD, MPH
Stanford University School of Medicine, Palo Alto, CA

"The Advocacy Community and Evidence-Based Therapeutics"

Ira Shoulson, MD, FAAN
University of Rochester Medical Center, Rochester, NY